SOPHiA GENETICS SA
SOPH
109 insider filings · Latest: Aug 13, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | Apr 8 8:04 PM | Ross MukenPresident | Sale | 2,600 | $4.85 | $12.6K | 700,521(D) | View → |
| Apr 7, 2026 | Apr 8 8:04 PM | Jurgi CamblongDirector, Chief Executive Officer | Sale | 2,500 | $4.86 | $12.2K | 3,728,950(D) | View → |
| Apr 6, 2026 | Apr 8 8:04 PM | Jurgi CamblongDirector, Chief Executive Officer | Sale | 2,600 | $4.85 | $12.6K | 3,731,450(D) | View → |
| Apr 7, 2026 | Apr 8 8:04 PM | George CardozaChief Financial Officer | Sale | 2,413 | $4.88 | $11.8K | 292,861(D) | View → |
| Apr 6, 2026 | Apr 8 8:04 PM | George CardozaChief Financial Officer | Sale | 2,520 | $4.85 | $12.2K | 295,274(D) | View → |
| Apr 7, 2026 | Apr 8 8:04 PM | Manuela ValenteChief People Officer | Sale | 2,376 | $4.87 | $11.6K | 219,275(D) | View → |
| Apr 6, 2026 | Apr 8 8:04 PM | Manuela ValenteChief People Officer | Sale | 2,597 | $4.85 | $12.6K | 221,651(D) | View → |
| Apr 7, 2026 | Apr 8 8:04 PM | Zhenyu XuChief Scientific Officer | Sale | 2,400 | $4.87 | $11.7K | 644,952(D) | View → |
| Apr 6, 2026 | Apr 8 8:04 PM | Zhenyu XuChief Scientific Officer | Sale | 2,700 | $4.85 | $13.1K | 647,352(D) | View → |
| Apr 7, 2026 | Apr 8 8:04 PM | Abhimanyu VermaChief Technology Officer | Sale | 1,030 | $4.87 | $5.0K | 204,400(D) | View → |
| Apr 6, 2026 | Apr 8 8:04 PM | Abhimanyu VermaChief Technology Officer | Sale | 2,519 | $4.86 | $12.2K | 205,430(D) | View → |
| Apr 6, 2026 | Apr 6 8:33 PM | ROSS J MUKEN | Proposed Sale | 20,689 | $5.04 | $104.3K | — | View → |
| Apr 6, 2026 | Apr 6 8:32 PM | DAAN GUIDO MARIA VAN WELL | Proposed Sale | 12,354 | $5.04 | $62.3K | — | View → |
| Apr 6, 2026 | Apr 6 8:32 PM | ZHENYU XU | Proposed Sale | 18,556 | $5.04 | $93.5K | — | View → |
| Apr 6, 2026 | Apr 6 8:31 PM | GEORGE CARDOZA | Proposed Sale | 6,335 | $5.04 | $31.9K | — | View → |
| Apr 6, 2026 | Apr 6 8:31 PM | PHILIPPE MENU | Proposed Sale | 19,556 | $5.04 | $98.6K | — | View → |
| Apr 6, 2026 | Apr 6 8:31 PM | MANUELA VALENTE | Proposed Sale | 8,797 | $5.04 | $44.3K | — | View → |
| Apr 6, 2026 | Apr 6 8:31 PM | JURGI CAMBLONG | Proposed Sale | 87,083 | $5.04 | $438.9K | — | View → |
| Mar 31, 2026 | Apr 1 2:41 PM | Kevin PuylaertChief Sales Officer | Sale | 3 | $4.71 | $14 | 92,383(D) | View → |
| Mar 19, 2026 | Mar 20 8:01 PM | Well Daan VanChief Legal Officer | Sale | 684 | $4.79 | $3.3K | 261,238(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | Apr 3 10:59 AM | Abhimanyu VermaChief Technology Officer | Grant/Award | 119,760 | $5.04 | 119,760(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Ross MukenPresident | Grant/Award | 628,743 | $5.04 | 628,743(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Philippe MenuChief Medical Officer | Grant/Award | 164,671 | $5.04 | 164,671(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Zhenyu XuChief Scientific Officer | Grant/Award | 164,671 | $5.04 | 164,671(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Jurgi CamblongDirector, Chief Executive Officer | Grant/Award | 628,743 | $5.04 | 628,743(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | Kevin PuylaertChief Sales Officer | Grant/Award | 82,335 | $5.04 | 82,335(D) | View → |
| Apr 2, 2026 | Apr 3 10:59 AM | George CardozaChief Financial Officer | Grant/Award | 164,671 | $5.04 | 164,671(D) | View → |
| Apr 2, 2026 | Apr 3 10:58 AM | Manuela ValenteChief People Officer | Grant/Award | 104,790 | $5.04 | 104,790(D) | View → |
| Apr 2, 2026 | Apr 3 10:58 AM | Well Daan VanChief Legal Officer | Grant/Award | 142,216 | $5.04 | 142,216(D) | View → |
← Previous
Page 2 of 2